Table 3.
Accuracyindicators of HPV mRNA test in 723 women with abnormal cytology and HPV DNA positive test shown by cytological gradea
| Cytology | No. of women tested | No. of women with colposcopy follow-up | No. of CIN2+ women | Test positivityb |
Sensitivityc |
Specificityd |
PPV |
NPV |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | ||||
| ASC-US | 175 | 103 | 25 | 47 | 38–56 | 72 | 51–88 | 74 | 63–84 | 47 | 31–64 | 89 | 79–96 |
| L-SIL | 399 | 254 | 48 | 36 | 31–41 | 67 | 52–80 | 72 | 65–78 | 36 | 26–46 | 90 | 85–94 |
| H-SIL+ | 149 | 132 | 101 | 70 | 62–77 | 70 | 60–79 | 42 | 25–61 | 80 | 70–88 | 30 | 17–46 |
Abbreviations are as defined in Table 1, footnote a.
Test positivity and its 95% CI are calculated based on the total number of tested women.
Sensitivity and its 95% CI are calculated based on the number of CIN2+ women.
Specificity and its 95% CI are calculated based on the number of CIN2− women, i.e., (the number of women withcolposcopy follow-up) − (the number of CIN2+ women).